| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | Dec 19, 2022 | NRX Pharmaceuticals, Inc. | CFO | Buy | 91.3 | +30,000 | 183.63% | ✗ | $33K |
| Nov 25, 2022 | Dec 19, 2022 | NRX Pharmaceuticals, Inc. | CFO | Buy | 91.3 | +16,337 | 100.00% | ✗ | $18.2K |
| Nov 25, 2022 | Nov 28, 2022 | NRX Pharmaceuticals, Inc. | CFO | Buy | 91.3 | +16,337 | 90.40% | ✗ | $18.2K |
| Jun 15, 2021 | Jun 17, 2021 | PDS Biotechnology Corp | CFO | Buy | 95.0 | +17,647 | 100.00% | ✗ | $150K |
| Feb 21, 2020 | Feb 24, 2020 | RESEARCH FRONTIERS INC | CFO | Buy | 95.0 | +91,554 | 65.91% | ✗ | $125K |
| Sep 12, 2017 | Sep 13, 2017 | RESEARCH FRONTIERS INC | CFO | Buy | 82.5 | +4,000 | 2.97% | ✗ | $4.6K |
| Jun 19, 2014 | Jun 19, 2014 | RESEARCH FRONTIERS INC | CFO | Buy | 78.8 | +2,000 | 1.38% | ✗ | $10.9K |
| Feb 10, 2011 | Feb 14, 2011 | RESEARCH FRONTIERS INC | CFO | Buy | 95.0 | +24,000 | 100.00% | ✗ | $207.6K |